These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 18675868)

  • 21. Application of rapid in vitro co-culture system of macrophages and T-cell subsets to assess the immunogenicity of dogs vaccinated with live attenuated Leishmania donovani centrin deleted parasites (LdCen-/-).
    Viana KF; Fiuza JA; Gannavaram S; Dey R; Selvapandiyan A; Bartholomeu DC; da Silveira-Lemos D; Bueno LL; Dutra WO; Fujiwara RT; Nakhasi HL; Giunchetti RC
    Parasit Vectors; 2016 Apr; 9():250. PubMed ID: 27136900
    [TBL] [Abstract][Full Text] [Related]  

  • 22. LBSapSal-vaccinated dogs exhibit increased circulating T-lymphocyte subsets (CD4⁺ and CD8⁺) as well as a reduction of parasitism after challenge with Leishmania infantum plus salivary gland of Lutzomyia longipalpis.
    Aguiar-Soares RD; Roatt BM; Ker HG; Moreira Nd; Mathias FA; Cardoso JM; Gontijo NF; Bruna-Romero O; Teixeira-Carvalho A; Martins-Filho OA; Corrêa-Oliveira R; Giunchetti RC; Reis AB
    Parasit Vectors; 2014 Feb; 7():61. PubMed ID: 24507702
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical value of anti-Leishmania (Leishmania) chagasi IgG titers detected by flow cytometry to distinguish infected from vaccinated dogs.
    de Andrade RA; Reis AB; Gontijo CM; Braga LB; Rocha RD; Araújo MS; Vianna LR; Martins-Filho OA
    Vet Immunol Immunopathol; 2007 Mar; 116(1-2):85-97. PubMed ID: 17287029
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of Live Recombinant Nonpathogenic Leishmania tarentolae Expressing Cysteine Proteinase and A2 Genes as a Candidate Vaccine against Experimental Canine Visceral Leishmaniasis.
    Shahbazi M; Zahedifard F; Taheri T; Taslimi Y; Jamshidi S; Shirian S; Mahdavi N; Hassankhani M; Daneshbod Y; Zarkesh-Esfahani SH; Papadopoulou B; Rafati S
    PLoS One; 2015; 10(7):e0132794. PubMed ID: 26197085
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Acylated and deacylated saponins of Quillaja saponaria mixture as adjuvants for the FML-vaccine against visceral leishmaniasis.
    Oliveira-Freitas E; Casas CP; Borja-Cabrera GP; Santos FN; Nico D; Souza LO; Tinoco LW; da Silva BP; Palatnik M; Parente JP; Palatnik-de-Sousa CB
    Vaccine; 2006 May; 24(18):3909-20. PubMed ID: 16556475
    [TBL] [Abstract][Full Text] [Related]  

  • 26. T-cell-derived cytokines, nitric oxide production by peripheral blood monocytes and seric anti-Leishmania (Leishmania) chagasi IgG subclass patterns following immunization against canine visceral leishmaniasis using Leishvaccine and Leishmune.
    Araújo MS; de Andrade RA; Sathler-Avelar R; Teixeira-Carvalho A; Andrade MC; Vianna LR; Mayrink W; Reis AB; Malaquias LC; Mello MN; Martins-Filho OA
    Vaccine; 2009 Feb; 27(7):1008-17. PubMed ID: 19110023
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A killed Leishmania vaccine with sand fly saliva extract and saponin adjuvant displays immunogenicity in dogs.
    Giunchetti RC; Corrêa-Oliveira R; Martins-Filho OA; Teixeira-Carvalho A; Roatt BM; de Oliveira Aguiar-Soares RD; Coura-Vital W; de Abreu RT; Malaquias LC; Gontijo NF; Brodskyn C; de Oliveira CI; Costa DJ; de Lana M; Reis AB
    Vaccine; 2008 Jan; 26(5):623-38. PubMed ID: 18180079
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunotherapy against experimental canine visceral leishmaniasis with the saponin enriched-Leishmune vaccine.
    Santos FN; Borja-Cabrera GP; Miyashiro LM; Grechi J; Reis AB; Moreira MA; Martins Filho OA; Luvizotto MC; Menz I; Pessôa LM; Gonçalves PR; Palatnik M; Palatnik-de-Sousa CB
    Vaccine; 2007 Aug; 25(33):6176-90. PubMed ID: 17630055
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunotherapy with the saponin enriched-Leishmune vaccine versus immunochemotherapy in dogs with natural canine visceral leishmaniasis.
    Borja-Cabrera GP; Santos FN; Santos FB; Trivellato FA; Kawasaki JK; Costa AC; Castro T; Nogueira FS; Moreira MA; Luvizotto MC; Palatnik M; Palatnik-de-Sousa CB
    Vaccine; 2010 Jan; 28(3):597-603. PubMed ID: 19800443
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vaccination against canine leishmaniosis increases the phagocytic activity, nitric oxide production and expression of cell activation/migration molecules in neutrophils and monocytes.
    Moreira ML; Costa-Pereira C; Alves ML; Marteleto BH; Ribeiro VM; Peruhype-Magalhães V; Giunchetti RC; Martins-Filho OA; Araújo MS
    Vet Parasitol; 2016 Apr; 220():33-45. PubMed ID: 26995719
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of the immunoprophylactic potential of a killed vaccine candidate in combination with different adjuvants against murine visceral leishmaniasis.
    Thakur A; Kaur H; Kaur S
    Parasitol Int; 2015 Feb; 64(1):70-8. PubMed ID: 25316605
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Humoral immunological profile and parasitological statuses of Leishmune vaccinated and visceral leishmaniasis infected dogs from an endemic area.
    de Amorim IF; Freitas E; Alves CF; Tafuri WL; Melo MN; Michalick MS; da Costa-Val AP
    Vet Parasitol; 2010 Oct; 173(1-2):55-63. PubMed ID: 20638182
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Despite Leishvaccine and Leishmune trigger distinct immune profiles, their ability to activate phagocytes and CD8+ T-cells support their high-quality immunogenic potential against canine visceral leishmaniasis.
    Araújo MS; de Andrade RA; Vianna LR; Mayrink W; Reis AB; Sathler-Avelar R; Teixeira-Carvalho A; Andrade MC; Mello MN; Martins-Filho OA
    Vaccine; 2008 Apr; 26(18):2211-24. PubMed ID: 18395948
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Histological study of cell migration in the dermis of hamsters after immunisation with two different vaccines against visceral leishmaniasis.
    Moreira Nd; Giunchetti RC; Carneiro CM; Vitoriano-Souza J; Roatt BM; Malaquias LC; Corrêa-Oliveira R; Reis AB
    Vet Immunol Immunopathol; 2009 Apr; 128(4):418-24. PubMed ID: 19147234
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ability of immunodiagnostic tests to differentiate between dogs naturally infected with Leishmania infantum and Leishmune(®)-vaccinated dogs.
    Ribeiro RA; Teixeira-Neto RG; Belo VS; Ferreira EC; Schallig HD; Silva ES
    Vet Res Commun; 2015 Jun; 39(2):87-95. PubMed ID: 25874857
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Multicomponent LBSap vaccine displays immunological and parasitological profiles similar to those of Leish-Tec® and Leishmune® vaccines against visceral leishmaniasis.
    de Mendonça LZ; Resende LA; Lanna MF; Aguiar-Soares RD; Roatt BM; Castro RA; Batista MA; Silveira-Lemos D; Gomes Jde A; Fujiwara RT; Rezende SA; Martins-Filho OA; Corrêa-Oliveira R; Dutra WO; Reis AB; Giunchetti RC
    Parasit Vectors; 2016 Aug; 9(1):472. PubMed ID: 27577735
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Field trial of efficacy of the Leish-tec® vaccine against canine leishmaniasis caused by Leishmania infantum in an endemic area with high transmission rates.
    Grimaldi G; Teva A; Dos-Santos CB; Santos FN; Pinto ID; Fux B; Leite GR; Falqueto A
    PLoS One; 2017; 12(9):e0185438. PubMed ID: 28953944
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of LbSapSal Vaccine in Canine Immunological and Parasitological Features before and after Leishmania chagasi-Challenge.
    Resende LA; Aguiar-Soares RD; Gama-Ker H; Roatt BM; Mendonça LZ; Alves ML; Silveira-Lemos Dd; Corrêa-Oliveira R; Martins-Filho OA; Araújo MS; Fujiwara RT; Gontijo NF; Reis AB; Giunchetti RC
    PLoS One; 2016; 11(8):e0161169. PubMed ID: 27556586
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Advances in flow cytometric serology for canine visceral leishmaniasis: diagnostic applications when distinct clinical forms, vaccination and other canine pathogens become a challenge.
    Andrade RA; Silva Araújo MS; Reis AB; Gontijo CM; Vianna LR; Mayrink W; Martins-Filho OA
    Vet Immunol Immunopathol; 2009 Mar; 128(1-3):79-86. PubMed ID: 19046772
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Vaccination of dogs with six different candidate leishmaniasis vaccines composed of a chimerical recombinant protein containing ribosomal and histone protein epitopes in combination with different adjuvants.
    Poot J; Janssen LH; van Kasteren-Westerneng TJ; van der Heijden-Liefkens KH; Schijns VE; Heckeroth A
    Vaccine; 2009 Jul; 27(33):4439-46. PubMed ID: 19500553
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.